DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from COVID-19 related ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback